In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole

Parasitology

Volumn 116, Issue 2, 1998, Pages 165-171

  Murta, S M F ^a,b   Romanha, A J ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Chemotherapy; Clones; Drug resistance; Experimental Chagas' disease; In vivo selection; Trypanosoma cruzi

Indexed keywords

2 AMINO 5 (1 METHYL 5 NITRO 2 IMIDAZOLYL) 1,3,4 THIADIAZOLE; 3A,4,5,6,7,7A HEXAHYDRO 3 (1 METHYL 5 NITRO 1H IMIDAZOL 2 YL) 1,2 BENZISOXAZOLE; BENZNIDAZOLE; NIFURTIMOX;

ANIMAL EXPERIMENT; ARTICLE; CHAGAS DISEASE; CLONE; CONTROLLED STUDY; DRUG RESISTANCE; EXPERIMENTAL MODEL; MALE; MOUSE; NONHUMAN; PARASITE CULTIVATION; PHENOTYPE; PRIORITY JOURNAL; TRYPANOSOMA CRUZI;

ANIMALS; CHAGAS DISEASE; DRUG RESISTANCE; MALE; MICE; NITROIMIDAZOLES; PARASITEMIA; PARASITOLOGY; PHENOTYPE; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

ANIMALIA; PROTOZOA; STAPHYLOCOCCUS PHAGE 3A; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0031984626     PISSN: 00311820     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0031182097002084     Document Type: Article

References (31)

1. ANDRADE, S. G., ANDRADE, Z. A. & FIGUEIRA, R. M. (1977). Estudo experimental sobre a resistência de uma cepa do Trypanosoma cruzi ao Bay 2502. Revista do Instituto de Medicina Tropical de São Paulo 19, 124-129.
2. ANDRADE, S. G. & FIGUEIRA, R. M. (1977). Estudo experimental sobre a açào terapêutica da droga Ro 7-1051 na infecçào por diferentes cepas do T. cruzi. Revista do Instituto de Medicina Tropical de São Paulo 19, 335-341.
3. ANDRADE, S., MAGALH̃AES, J. B. & PONTES, A. L. (1985). Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types. Bulletin of the World Health Organization 63, 721-726.
4. ANDRADE, S. G., SILVA, R. C. & SANTIAGO, C. M. G. (1989). Treatment of chronic experimental Trypanosoma cruzi infections in mice with MK-436, a 2-substituted 5-nitroimidazole. Bulletin of the World Health Organization 67, 509-514.
5. BOCK, M., GONNERT, R. & HABERKORN, A. (1969). Studies with Bay 2502 on animals. Boletín Chileno de Parasitologia 24, 13-19.
6. BRENER, Z. (1962). Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Revista do Instituto de Medicina Tropical de São Paulo 4, 389-396.
7. BRENER, Z., COSTA, A. G. & CHIARI, E. (1976). Differences in the susceptibility of Trypanosoma cruzi strains to active chemotherapeutic agents. Revista do Instituto de Medicina Tropical de São Paulo 18, 450-455.
8. CAMARGO, E. P. (1964). Growth and differentiation in Trypanosoma cruzi. I. Origin of metacyclic trypanosomes in liquid media. Revista do Instituto de Medicina Tropical de São Paulo 6, 93-100.
9. DALLAGIOVANNA, B., CASTANYS, S. & GAMARRO, F. (1994). Trypanosoma cruzi: sequence of the ATP-binding site of a P-glycoprotein gene. Experimental Parasitology 79, 63-67.
10. DALLAGIOVANNA, B., GAMARRO, F. & CASTANYS, S. (1996). Molecular characterization of a P-glycoprotein-related tcpgp2 gene in Trypanosoma cruzi. Molecular and Biochemical Parasitology 75, 145-157.
11. DVORAK, J. A. & HOWE, C. L. (1977). The effects of Lampit (Bayer 2402) on the interaction of Trypanosoma cruzi with vertebrate cells in vitro. American Journal of Tropical Medicine and Hygiene 26, 58-63.
12. FILARDI, L. S. & BRENER, Z. (1982). A nitroimidazole-thiadiazole derivative with curative action in experimental Trypanosoma cruzi infections. Annals of Tropical Medicine and Parasitology 76, 293-297.
13. FILARDI, L. S. & BRENER, Z. (1984). A rapid method for testing in vivo the susceptibility of different strains of Trypanosoma cruzi to active chemotherapeutic agents. Memórias do Instituto Oswaldo Cruz 79, 221-225.
14. FILARDI, L. S. & BRENER, Z. (1987). Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas' disease. Transactions of the Royal Society of Tropical Medicine and Hygiene 81, 755-759.
15. FINLEY, R. W. & DVORAK, J. A. (1987). Trypanosoma cruzi: analysis of the population dynamics of heterogeneous mixtures. Journal of Protozoology 34, 409-415.
16. GOMES, M. L., MARQUES DE ARAÚJO, S. & CHIARI, E. (1991). Trypanosoma cruzi: growth of clones on solid medium using culture and blood forms. Memórias do Instituto Oswaldo Cruz 86, 131-132.
17. GOTTESMAN, M. M. & PASTAN, I. (1993). Biochemistry of multidrug resistance mediated by the multidrug transporter. Annual Review of Biochemistry 62, 385-427.
18. HABERKORN, A. & GONNERT, R. (1972). Animal experimental investigations in the activity of nifurtimox against Trypanosoma cruzi. Arzneimittel-Forschung 22, 1570-1580.
19. HAUSCHKA, T. S. (1949). Persistence of strain-specific behavior in two strains of Trypanosoma cruzi after prolonged transfer through inbred mice. Journal of Parasitology 35, 593-599.
20. NEAL, R. A. & VAN BUEREN, J. (1988). Comparative studies of drug susceptibility of five strains of Trypanosoma cruzi in vivo and in vitro. Transactions of the Royal Society of Tropical Medicine and Hygiene 82, 709-714.
21. NIRDÉ, P., LARROQUE, C. & BARNABE, C. (1995). Drug-resistant epimastigotes of Trypanosoma cruzi and persistence of this phenotype after differentiation into amastigotes. Medical Sciences 318, 1239-1244.
22. NOZAKI, T., ENGEL, J. & DVORAK, J. (1996). Cellular and molecular biological analyses of nifurtimox reistance in Trypanosoma cruzi. American Journal of Tropical Medicine and Hygiene 55, 111-117.
23. PEREIRA DA SILVA, L. H. & NUSSENZWEIG, V. (1953). Sobre uma cepa de Trypanosoma cruzi altamente virulenta para o camundongo branco. Folia Clinica et Biologica 20, 191-208.
24. POSTAN, M., McDANIEL, J. P. & DVORAK, J. A. (1986). Trypanosoma cruzi: constancy of clone pathogenicity for inbred mice during long-term in vitro maintenance. Transactions of the Royal Society of Tropical Medicine and Hygiene 80, 659-662.
25. RAAFLAUB, J. & ZIEGLER, W. H. (1979). Single-dose pharmacokinetics of the trypanosomicide benznidazole in man. Arzneimittel-Forschung 29, 1611-1614.
26. RASSI, A. & LUQUETTI, A. O. (1992). Therapy of Chagas disease. In Chagas Disease (American Trypanosomiasis) : its Impact on Transfusion and Clinical Medicine (ed. Wendel, S., Brener, Z., Camargo, M. E. & Rassi, A.), pp. 237-247. ISBT Brazil 1992, São Paulo, Brazil.
27. RIBEIRO-RODRIGUES, R., DOS SANTOS, W., OMVEIRA, A. B., SNIECKUS, V., ZANI, C. & ROMANHA, A. (1995). Growth inhibitory effect of nafthofuran and nafthofuranquinone derivatives on Trypanosoma cruzi epimastigotes. Bioorganic and Medicinal Chemistry Letters 5, 1509-1512.
28. SCOTT, V. R. & MATTHEWS, T. R. (1987). The efficacy of an n-substituted imidazole, RS-49676, against a Trypanosoma cruzi infection in mice. American Journal of Tropical Medicine and Hygiene 37, 308-313.
29. ULLMAN, B. (1995). Multidrug resistance and P-glycoprotein in parasitic Protozoa. Journal of Bioenergetics and Biomembranes 27, 77-84.
30. URBINA, J., PAYARES, G., MOLINA, J., SANOJA, C., LIENDO, A., LAZARDI, K., PIRAS, M., PIRAS, R., PEREZ, N., WINCKER, P. & RYLEY, J. (1996). Cure of short- and long-term experimental Chagas' disease using D0870. Science 273, 969-971.
31. WORLD HEALTH ORGANIZATION (1991). Control of Chagas disease. WHO Technical Report Series No. 811. WHO, Geneva.